Ambiguous results of an attempt to withdraw barbiturates in epilepsy patients with intellectual disability.

Author: BocchicchioM, HauserI, HorstmannV, HuberBernd, JokeitG, MayT, MeinertT, RobertsonE, SchorlemmerH, SchulzL, SeidelM, WagnerW

Paper Details 
Original Abstract of the Article :
Phenobarbital and primidone frequently have adverse effects on mental functions. Therefore, an attempt was made to taper barbiturates in 85 patients out of a resident population with epilepsy and intellectual disability who were selected according to clinical criteria. The objectives were to reduce ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.seizure.2008.07.006

データ提供:米国国立医学図書館(NLM)

The Challenges of Barbiturate Withdrawal in Epilepsy Patients

This study explores the complex and challenging world of barbiturate withdrawal in epilepsy patients with intellectual disability. Imagine a desert landscape where individuals struggle with seizures, like unpredictable sandstorms, and rely on medication, like a sturdy caravan shelter, for protection. The study investigates the delicate process of withdrawing barbiturates from these patients, seeking to improve their cognitive function and quality of life while minimizing the risk of seizure exacerbation.

Navigating the Terrain of Barbiturate Withdrawal

The study found that barbiturate withdrawal in epilepsy patients with intellectual disability can be a complex and challenging process, with a significant risk of seizure exacerbation. This is like attempting to dismantle a caravan shelter during a sandstorm, a risky endeavor that requires careful planning and execution. The research highlights the need for personalized approaches and careful monitoring during withdrawal, emphasizing the importance of individualizing treatment based on patient characteristics and risk factors.

Improving Outcomes for Epilepsy Patients

This research underscores the importance of addressing the unique needs of epilepsy patients with intellectual disability, seeking to balance the benefits of medication with the potential risks of withdrawal. It's like exploring a vast and challenging desert, seeking out hidden pathways and solutions for improving the lives of those affected by this complex condition. The study's findings emphasize the need for continued research to develop safer and more effective strategies for managing epilepsy in this population.

Dr.Camel's Conclusion

This research provides valuable insights into the challenges of barbiturate withdrawal in epilepsy patients with intellectual disability, highlighting the importance of individualized care and careful monitoring during this process. It's like navigating a treacherous desert, seeking out hidden pathways and solutions to ensure the safety and well-being of those affected. The study's findings underscore the need for continued research to develop more effective and less intrusive treatment options for epilepsy, promoting a brighter future for those living with this challenging condition.

Date :
  1. Date Completed 2009-04-30
  2. Date Revised 2014-10-21
Further Info :

Pubmed ID

18760938

DOI: Digital Object Identifier

10.1016/j.seizure.2008.07.006

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.